Oncology
Standard & Poor's Initiates Factual Stock Report Coverage on Spectrum Pharmaceuticals, Inc.
Published in Healthcare Mergers, Acquisitions and Ventures Week, March 1st, 2008
Spectrum Pharmaceuticals, Inc. (NGM:SPPI), a biopharmaceutical company, engages in the acquisition, development, and commercialization of oncology, urology and other drug candidates. The company has a number of drugs in development, including several in late stage clinical development.
In November 2007, the Company announced that the FDA has targeted March 7, 2008 as its action date regarding the approval of the ISO-Vorin(TM) New Drug Application.
In April 2006, the company acquired the oncology drug assets of Targent,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 6 Day Dental & Orthodontics
Mighty Molar Man(R) Accepts Plano Mayor Pat Evans's Proclamation in Honor of National Dental Health Month - Abnormal Psychology
Abnormal Psychology, 2nd Edition Available Now - AcademyHealth
Report Lists Key Policy Questions Facing State, National Health Reform - Acne Vulgaris
Recent Studies Suggest Popular 'Diet Pill' Relacore Reduces Acne Breakouts - Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. Announces Exercise of Option by Underwriters - Acrongenomics, Inc.
Acrongenomics on Track to Acquire Molecular Vision - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
